Hypophosphatemia: A Common but Overlooked Cause of Cardiac Dysfunction in a Child with DKA

Ashish Agarwal1, G Sathwik2, Shankar Prasad1

  • 1Division of Pediatric Emergency and Intensive Care Units, Department of Pediatrics, Advanced Pediatrics Center, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.

Insights

Severe hypophosphatemia is a rare but serious complication during diabetic ketoacidosis management in children. Prompt correction of low phosphate levels is crucial for preventing life-threatening cardiac issues.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Metabolic Disorders

Background:

  • Diabetic ketoacidosis (DKA) is a severe complication of type 1 diabetes mellitus (T1DM) in children.
  • DKA management can lead to various complications, including electrolyte imbalances like hypophosphatemia.
  • While asymptomatic hypophosphatemia is common, severe symptomatic cases are rare but potentially life-threatening.

Observation:

  • A case of a newly diagnosed T1DM child experiencing DKA is presented.
  • During DKA management, the patient developed severe symptomatic hypophosphatemia.
  • This led to significant cardiac complications, including arrhythmias and cardiac dysfunction.

Findings:

  • Severe hypophosphatemia can manifest with serious cardiac complications in pediatric DKA patients.
  • These complications include arrhythmias and impaired cardiac function.
  • The patient's cardiac status improved significantly with prompt recognition and correction of hypophosphatemia.

Implications:

  • Highlights the importance of vigilant electrolyte monitoring during DKA treatment in children.
  • Emphasizes that severe symptomatic hypophosphatemia, though rare, requires immediate attention due to its potential for critical cardiac events.
  • Suggests that timely intervention for hypophosphatemia can prevent severe morbidity and mortality in pediatric DKA.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
56
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
215
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
308
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
627